Primobolan

ACTIVE INGREDIENT

Each mL contains:

• Methenolone Enanthate 100 mg

DESCRIPTION

Primobolan (Methenolone Enanthate) 100 mg is an injectable anabolic steroid derived from dihydrotestosterone (DHT). It is formulated as an oil-based solution for intramuscular injection. Known for its mild anabolic effects with low androgenic activity, Primobolan is used in both medical and performance settings to promote muscle retention and improve nitrogen retention without significant water retention or estrogenic side effects, making it popular for cutting phases.

PHARMACOLOGICAL PROPERTIES

Mechanism of Action: Methenolone binds to androgen receptors, enhancing protein synthesis and nitrogen retention in muscle tissues. It exhibits mild anabolic effects with very low androgenic and estrogenic activity, making it suitable for users seeking muscle preservation without the risk of water retention or significant side effects.

Pharmacokinetics:

• Absorption: Methenolone Enanthate is slowly released after intramuscular injection, with a half-life of approximately 7–10 days.
• Distribution: It is widely distributed in muscle tissues with a high binding affinity for plasma proteins.
• Metabolism: Metabolized in the liver.
• Excretion: Excreted primarily through urine as metabolites.

INDICATIONS

Primobolan 100 mg is indicated for:

Muscle-wasting diseases: To prevent muscle loss and improve nitrogen retention in patients with chronic illness.

Performance enhancement: Used by athletes and bodybuilders to preserve lean muscle mass during cutting phases and to enhance muscle definition with minimal water retention or risk of estrogen-related side effects.

DOSAGE AND ADMINISTRATION

Dosage:

• Medical Use: 100–200 mg administered once every 1–2 weeks, depending on the clinical condition and response to treatment.
• Anabolic/Bodybuilding Use: Common doses range from 400 mg to 800 mg per week, depending on individual goals, tolerance, and experience. Typically administered twice per week to maintain stable blood levels.

Administration:

• Administer via deep intramuscular injection. Rotate injection sites regularly to prevent localized irritation. Inject the oil-based solution slowly to minimize pain and discomfort.

CONTRAINDICATIONS

• Hypersensitivity to methenolone or any component of the formulation.
• Pregnancy and lactation (Pregnancy Category X).
• Active or suspected prostate or breast cancer in males.
• Severe hepatic, renal, or cardiovascular disease.

WARNINGS AND PRECAUTIONS

1. Hepatic Effects: While methenolone is considered less hepatotoxic than many anabolic steroids, long-term use may still affect liver function. Periodic liver function tests are recommended, especially during prolonged use.

2. Cardiovascular Risks: Anabolic steroids may increase the risk of cardiovascular issues, including hypertension and lipid profile disturbances. Monitor cardiovascular health, particularly in long-term users or those with preexisting heart conditions.

3. Androgenic Effects: Methenolone has low androgenic activity, but in high doses or prolonged use, it may still cause androgenic side effects such as acne, hair loss, and virilization in women. Female users should exercise caution.

4. Lipid Profile: Methenolone may negatively affect cholesterol levels, lowering HDL (good cholesterol) and raising LDL (bad cholesterol). Regular lipid profile monitoring is advised.

5. Suppression of Natural Testosterone: Primobolan, though mild, can suppress endogenous testosterone production, particularly in higher doses. Post-cycle therapy (PCT) may be required to restore normal testosterone levels following discontinuation.

ADVERSE REACTIONS

Common adverse reactions:

• Acne
• Oily skin
• Hair thinning or loss (androgenic alopecia)
• Mild mood changes or irritability

Serious adverse reactions:

• Hepatotoxicity: Rare cases of liver enzyme elevations.
• Cardiovascular: Increased risk of hypertension, dyslipidemia, or cardiovascular events.
• Endocrine: Suppression of natural testosterone, gynecomastia (in men with other anabolic steroids), or testicular atrophy.
• Virilization (in women): Deepening of the voice, menstrual irregularities, or facial hair growth.

INTERACTIONS

1. Anticoagulants: Methenolone may enhance the effects of anticoagulants such as warfarin, increasing the risk of bleeding. Monitor coagulation status closely.

2. Insulin and Oral Antidiabetics: Methenolone may affect blood glucose levels, potentially requiring dose adjustments of insulin or oral antidiabetic medications.

3. Corticosteroids: Combined use of corticosteroids with methenolone may increase the risk of fluid retention and electrolyte imbalance.

USE IN SPECIFIC POPULATIONS

Pregnancy and Lactation: Primobolan is contraindicated in pregnant and breastfeeding women due to its potential teratogenic effects (Pregnancy Category X).

Pediatric Use: Not recommended for use in children or adolescents due to the risk of affecting growth and development.

Geriatric Use: Use with caution in elderly patients, as they may be more susceptible to adverse effects, particularly on the liver and cardiovascular system.

OVERDOSAGE

There is no specific antidote for methenolone overdose. In case of overdose, provide supportive and symptomatic care. Monitor liver function and cardiovascular status closely.

STORAGE

Store below 25°C (77°F). Protect from light. Do not refrigerate or freeze. Keep out of reach of children.

PACKAGING

Primobolan 100 mg is supplied in 10 mL vials, each containing 100 mg of methenolone enanthate in an oil-based solution.

MANUFACTURER

Oxydine Metabolics Switzerland

Oxydine.org
Hi@Oxydine.org